亮晴控股主要在香港提供医学美容服务，经营医学美容中心并销售护肤产品。所得款项中，约0.5亿港 元将用于补充一般营运资金，包括支付员工成本、租金开支及其他业务及公司开支。本次发行根据股东 大会授予的一般授权实施，预计于相关条件达成后五个营业日内完成。 点击查看公告原文>> 二零二五年十一月十九日，亮晴控股（股份代号：8603）公告称，通过一般授权以"配售新股份"方式融 资，其中配售新股份发行18,920,000股（约0.2亿股），募集约0.5亿港元；以上合计募集资金约0.5亿港 元（扣除费用后净得约0.5亿港元）。 配售新股份配售价2.61港元较前一交易日收市价3.18港元折让约17.9%，较前五个交易日平均收市价折 让约19.9%。配售股份占现有已发行股本约2.4%，完成后占扩大股本约2.3%。 来源：新浪港股-好仓工作室 声明：市场有风险，投资需谨慎。 本文为AI大模型基于第三方数据库自动发布，任何在本文出现的信 息（包括但不限于个股、评论、预测、图表、指标、理论、任何形式的表述等）均只作为参考，不构成 个人投资建议。受限于第三方数据库质量等问题，我们无法对数据的真实性及完整性进行分辨或核验， 因此本文内容 ...

Investment Rating - The investment rating for the company is "Buy" and is maintained [6]. Core Insights - The company reported a revenue of 7.098 billion yuan for Q1-Q3 2025, representing a year-on-year growth of 1.9%. The net profit attributable to shareholders was 1.03 billion yuan, up 2.65% year-on-year. However, in Q3 alone, revenue decreased by 11.6% to 1.74 billion yuan, and net profit fell by 23.6% to 230 million yuan [2][4]. Revenue Analysis - In Q3 2025, the company experienced seasonal pressure on revenue, with skincare, beauty makeup, and hair care categories generating revenues of 1.32 billion, 240 million, and 180 million yuan respectively. The year-on-year growth rates were -20.4%, 0.9%, and 138% respectively. The main brand, focused on skincare, faced challenges, while the OR brand, focused on hair care, showed strong growth [10]. Profitability Analysis - The gross margin continued to improve, with a net profit margin of 13.1% in Q3, down 2.1 percentage points year-on-year. The gross margin increased by 3.96 percentage points to 74.7%, attributed to category structure optimization and cost reduction efforts. However, selling, administrative, research and development, and financial expense ratios increased by a total of 6.8 percentage points [10]. Investment Recommendations - Given the current challenges faced by the main brand and the increase in expense ratios, the company is experiencing temporary pressure on revenue and net profit. However, the main brand maintains a strong comparative advantage due to a well-rounded product matrix. The OR brand is expected to contribute additional growth in the future. The projected EPS for 2025-2027 is 3.97, 4.44, and 5.00 yuan per share respectively [10].

Core Insights - Yatsen E-commerce reported a revenue of 1 billion yuan for Q3 2025, marking a 47.5% increase year-on-year, achieving revenue growth for four consecutive quarters [1] - The color cosmetics segment grew by 25.2% year-on-year, while the skincare segment saw a significant increase of 83.2% to 491 million yuan [1] - R&D investment reached 39.76 million yuan in Q3, up 56.9% year-on-year, with R&D expense ratio increasing to 4% [1] - Since its IPO in 2020, Yatsen E-commerce has invested over 650 million yuan in R&D, maintaining an R&D expense ratio of over 3% for three consecutive years [1] - For Q4 2025, total revenue is expected to be between 1.32 billion and 1.49 billion yuan, representing a year-on-year growth of approximately 15% to 30% [1]

Company Overview - Ying Tong Holdings is a leading high-end perfume brand management company in China, providing distribution and market deployment services for 73 external brands as of FY25 [1] - The company is expected to benefit from the recovery of high-end consumption and the increasing penetration rate of perfumes and fragrances [1][2] - Ying Tong's brand matrix is continuously expanding, with plans to enhance self-operated retail stores and proprietary brands, which are anticipated to create new revenue and profit growth points [1][3] Industry Insights - The Chinese perfume market is projected to reach 26.5 billion yuan in 2024, with a CAGR of 15.1% from 2019 to 2024, significantly higher than the global expected growth rate of 3.5% during the same period [2] - Currently, over 50% of the domestic perfume market is dominated by overseas luxury brands, indicating a substantial opportunity for domestic brands to increase their market share [2] - The demand for perfumes in China has considerable room for growth compared to Europe and the United States, particularly in the extension from perfumes to fragrances, which could enhance market education and expand the "olfactory economy" [2] Competitive Advantages - Ying Tong has established a rich brand matrix ranging from affordable to luxury, covering various categories including skincare, home fragrances, and personal care [2] - The company maintains stable long-term relationships with its top two suppliers, EuroItalia and Yite, which accounted for 59.4% of total procurement in FY25 [2] - Ying Tong has a comprehensive channel layout with 8,302 offline sales points in China as of FY25, alongside steady growth in online channels [2] Growth Opportunities - The company is launching self-operated retail stores, such as the multi-brand perfume and fragrance collection store "Shi Fen Qi He," to enhance customer experience and increase sales [3] - Ying Tong is actively developing its proprietary brand, Santa Monica, which is expanding into eyewear, perfumes, and fragrances, with a projected CAGR of 41% for brand revenue from FY24 to FY25 [3] - The company is also exploring external acquisitions to diversify its brand matrix and deepen its channel layout [3] Market Positioning - There are concerns regarding the sustainability of the brand management model; however, historical analysis of leading overseas perfume management companies suggests that local distributors are essential for rapid market coverage and scale operations [3] - Ying Tong's operational experience and channel resources provide a unique advantage for sustainable development in the domestic market [3] Financial Projections - The company forecasts net profits of 261 million yuan, 327 million yuan, and 412 million yuan for FY26E, FY27E, and FY28E, respectively, with corresponding EPS of 0.19 yuan, 0.24 yuan, and 0.30 yuan [4] - A target price of 2.86 HKD is set, corresponding to a 14X FY26E PE, reflecting the company's growth potential and market positioning [4]

Investment Rating - The report maintains an "Outperform" rating for the company, with a target price of RMB 10.50 based on a target PE of 35x for 2026 [4][13]. Core Insights - The company has turned around after four years of adjustments, entering a growth phase with improved revenue and profit [4][14]. - For the first three quarters of 2025, revenue, net profit attributable to shareholders, and recurring net profit were RMB 1.55 billion, RMB 111 million, and RMB 75 million, representing year-on-year increases of 12.00%, 246.98%, and 146.48% respectively [4][14]. - The mask category has shown significant growth, leading the overall revenue increase, while the company is expected to gain market share as the industry recovers from a downturn [4][16]. Financial Summary - Revenue projections for 2025-2027 are RMB 2.185 billion, RMB 2.446 billion, and RMB 2.689 billion, with respective growth rates of 12.6%, 11.9%, and 9.9% [3][5]. - Net profit attributable to shareholders is forecasted to be RMB 142 million, RMB 154 million, and RMB 203 million for 2025-2027, with growth rates of 160.0%, 8.5%, and 31.4% [3][5]. - The company's gross profit margin for Q3 2025 was 21.77%, up 2.83% year-on-year, indicating improved operational efficiency [4][14]. Product Category Performance - In H1 2025, revenue from masks, skincare, and wipes was RMB 450 million, RMB 323 million, and RMB 125 million, with year-on-year growth of 21%, 7%, and a decline of 9% respectively [4][15]. - The gross profit margins for masks, skincare, and wipes were 19.01%, 16.67%, and 13.45%, reflecting improvements due to increased capacity utilization and revenue growth [4][15]. Industry Outlook - The cosmetics industry has faced a downturn since 2022, leading to intensified competition and the exit of smaller players, which is expected to benefit leading companies like the report's subject [4][16]. - The company's subsidiary, North Bell, is positioned to attract quality brands and gain market share due to its scale advantages and ongoing R&D investments [4][16].

新媒体统筹：丁青云 曾婷芳 赖禧 黄达迅 南方财经21世纪经济报道记者 高江虹、李依农 上海报道 在接受南方财经采访时，杜嘉班纳美妆首席执行官詹卢卡·托尼奥洛（Gianluca Toniolo）分享了品牌在 中国市场的发展理念与战略。他表示，今年对杜嘉班纳美妆而言意义非凡，参加进博会不仅是一次展 示，更是一种向中国消费者表态的机会。通过香水、彩妆和护肤等丰富产品系列，以及数字化工具，品 牌希望为消费者提供沉浸式的体验，让他们能够亲身试用、感受产品，并找到最适合自己的选择。托尼 奥洛强调，意大利文化与中国文化相近，未来品牌希望与中国艺术家共同打造美妆产品，通过产品展现 中意文化魅力。他指出，杜嘉班纳在产品设计上坚持将经典与创新融合，并通过奢华包装与高品质性 能，为消费者带来独特的品牌体验。 策划：赵海建 监制：施诗 编辑：和佳 记者：高江虹 李依农 剪辑：李群 （原标题：杜嘉班纳美妆首席执行官：希望共同打造展现中意文化的产品） 海外运营监制: 黄燕淑 海外运营内容统筹: 黄子豪 海外运营编辑：庄欢 吴婉婕 龙李华 郑全怡 出品：南方财经全媒体集团 ...

Core Viewpoint - The company reported its Q3 2025 results, showing a revenue increase of 25.5% year-on-year, with a net profit growth of 2.13% [1][2]. Financial Performance - For Q1-Q3 2025, the company achieved revenue of 2.45 billion yuan, with a net profit of 240 million yuan [1]. - In Q3 alone, revenue reached 690 million yuan, reflecting a 14.3% year-on-year growth, while net profit was 69.48 million yuan, up 11.6% year-on-year [1]. - The non-recurring net profit decreased by 20% year-on-year in Q3 [1]. Segment Performance - In Q3 2025, revenue by product category was as follows: eye care (150 million yuan, +20%), skincare (310 million yuan, +42%), cleansing (70 million yuan, +23%), and beauty products (150 million yuan, -27%) [2]. - The main brand is expected to maintain good growth, while the sub-brand "Lianhuo" is under pressure [2]. - Average prices for skincare products increased due to a higher sales proportion of eye care products and a decrease in lower-priced eye care product sales [2]. Profitability Analysis - For Q1-Q3 2025, the net profit margin decreased by 2.3 percentage points to 10% [2]. - Gross margin slightly increased by 0.3 percentage points to 74.9% [2]. - The increase in sales, management, and R&D expense ratios contributed to a total expense ratio increase of 3.1 percentage points [2]. Investment Outlook - The company continues to implement a big product strategy, with its two main brands, "Marubi" and "Lianhuo," showing sustained growth [3]. - New products like "Little Gold Needle Cream" and "Little Gold Needle Mask" are expected to contribute to growth [3]. - EPS forecasts for 2025, 2026, and 2027 are 0.95, 1.12, and 1.29 yuan per share, respectively, maintaining a "buy" rating [3].

Investment Rating - The investment rating for the company is "Buy" and is maintained [6]. Core Insights - The company reported a revenue of 2.45 billion yuan for Q1-Q3 2025, representing a year-on-year growth of 25.5%. The net profit attributable to shareholders was 240 million yuan, up 2.13% year-on-year. In Q3 alone, revenue reached 690 million yuan, a 14.3% increase year-on-year, while net profit attributable to shareholders was 69.48 million yuan, growing by 11.6% year-on-year. However, the non-recurring net profit saw a decline of 20% year-on-year [2][4]. Summary by Sections Revenue Performance - For Q3 2025, the company achieved revenue of 1.5 billion yuan from eye care products, 3.1 billion yuan from skincare, 0.7 billion yuan from cleansing products, and 1.5 billion yuan from beauty products, with year-on-year growth rates of 20%, 42%, 23%, and -27% respectively. The main brand is expected to maintain good growth, while the beauty category is under pressure [9]. Profitability Analysis - In the first three quarters of 2025, the net profit margin decreased by 2.3 percentage points to 10%. This was attributed to a slight increase in gross margin by 0.3 percentage points to 74.9%, while sales, management, and R&D expense ratios increased by a total of 3.1 percentage points [9]. Investment Recommendations - The company is expected to continue its large product strategy, with the main brands, Marubi and Lianhuo, maintaining growth momentum. New products such as the "Little Gold Needle" cream and mask are being introduced, indicating significant growth potential. The forecasted EPS for 2025-2027 is 0.95, 1.12, and 1.29 yuan per share respectively, with a "Buy" rating maintained [9].

Group 1 - The core viewpoint of the articles emphasizes that the China International Import Expo serves as a significant platform for global companies to access the Chinese market, with Kao Group highlighting its commitment to innovation and local adaptation [1][2] - Kao Group's theme for the expo, "Coexistence of Beauty and Quality for the Future," reflects its dedication to integrating global innovation with local needs, showcasing its 138 years of brand heritage [1][2] - The VIC technology and quality exhibition area at Kao's booth illustrates the company's focus on consumer co-creation and transforming consumer pain points into innovative solutions, emphasizing a consumer-driven research approach [1][2] Group 2 - Kao Group's collaborative model between its Japanese headquarters and Chinese R&D center allows for effective localization of technology, ensuring that innovations meet the diverse needs of Chinese consumers [2] - The company is recognized for providing a "green innovation model" for the high-quality development of the Chinese cosmetics industry, integrating global experience with local practices [2] - Kao's innovations extend beyond personal care to green agriculture, with products like flower preservation solutions and soil improvement agents that enhance agricultural efficiency and sustainability [3]

Investment Rating - The report maintains a "Buy" rating for the company [4][6]. Core Insights - The company reported a revenue of 7.1 billion yuan for the first three quarters of 2025, a year-on-year increase of 1.9%, with a net profit attributable to shareholders of 1.03 billion yuan, also up 2.7% year-on-year [1]. - In Q3 2025, the skincare segment saw a significant decline in revenue by 20.4%, while the hair care segment experienced remarkable growth of 137.7% [2]. - The gross margin for the first three quarters improved by 3.6 percentage points to 73.7%, while the expense ratio increased by 3.6 percentage points to 55.3% [3]. Summary by Sections Financial Performance - Q3 2025 revenue was 1.74 billion yuan, down 11.6% year-on-year, with net profit at 0.23 billion yuan, down 23.6% year-on-year [1][2]. - The gross margin for Q3 2025 was 74.7%, reflecting a year-on-year increase of 4.0 percentage points [3]. Profitability Forecast - The net profit forecasts for 2025, 2026, and 2027 have been revised downwards by 15%, 14%, and 13% respectively, with projected net profits of 1.53 billion, 1.79 billion, and 2.07 billion yuan [4]. - The earnings per share (EPS) estimates for the same years are 3.86, 4.52, and 5.22 yuan, with corresponding price-to-earnings (P/E) ratios of 20, 17, and 15 [4]. Cash Flow and Inventory Management - Operating cash flow for the first three quarters of 2025 was 1.2 billion yuan, an increase of 196.7% year-on-year [3]. - Inventory as of September 2025 increased by 47.6% from the beginning of the year to 0.98 billion yuan, while accounts receivable decreased by 38.5% to 0.32 billion yuan [3].